Comparative Safety of In Utero Exposure to Buprenorphine Combined With Naloxone vs Buprenorphine Alone.
Buprenorphine 與 Naloxone 聯合使用與單獨使用 Buprenorphine 在子宮內暴露的比較安全性。
JAMA 2024-08-12
Experiences of Parents with Opioid Use Disorder during Their Attempts to Seek Treatment: A Qualitative Analysis.
家長在尋求治療時患有阿片類物質使用障礙的經驗:質性分析。
Int J Environ Res Public Health 2023-01-23
Assessment of the Risk Evaluation and Mitigation Strategy (REMS) for Phentermine-Topiramate to Prevent Exposure During Pregnancy.
評估Phentermine-Topiramate的風險評估與減輕策略(REMS)以預防懷孕期間的暴露。
Ann Intern Med 2023-04-27
Case Series: Exposure to Glucagon-like Peptide-1 Receptor Agonist in the First Trimester of Pregnancy in Two Siblings.
病例系列:兩個同胞在懷孕第一季度暴露於類胰高血糖素-1受體激動劑。
Endocr Metab Immune Disord Drug Targets 2023-11-08
Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy.
GLP-1 受體激動劑及其他第二線抗糖尿病藥物在早期懷孕中的安全性。
JAMA Intern Med 2024-02-06
Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services.
GLP1受體激動劑在早期懷孕中的使用及生殖安全性:基於六個胎兒學資訊服務數據庫的多中心、觀察性、前瞻性cohort研究。
BMJ Open 2024-04-27
Effect of combined GLP-1 analogue and bupropion/naltrexone on weight loss: a retrospective cohort study.
結合 GLP-1 類似物與 bupropion/naltrexone 對減重的影響:一項回顧性群體研究。
Int J Obes (Lond) 2024-05-09
Subcutaneous Semaglutide during Breastfeeding: Infant Safety Regarding Drug Transfer into Human Milk.
哺乳期間使用皮下 Semaglutide:藥物轉移至人乳的嬰兒安全性。
Nutrients 2024-09-14